Finance

Beta
Lists
1733:TPE
Apex Biotechnology Corp
NT$29.25
+0.52%
(+0.15) 1D
Jun 12, 1:30:19 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1733...
Open
NT$29.20
High
NT$29.30
Low
NT$29.10
Mkt. cap
2.92B
Avg. vol.
218.78K
Volume
96.23K
Dividend
4.44%
Quarterly dividend
NT$0.32
Ex-dividend date
Jun 9, 2026
P/E ratio
16.17
52-wk high
NT$38.70
52-wk low
NT$27.00
EPS
NT$1.81
Shares outstanding
99.69M
No. of employees
641
Open
NT$29.20
High
NT$29.30
Low
NT$29.10
Mkt. cap
2.92B
Avg. vol.
218.78K
Volume
96.23K
Dividend
4.44%
Quarterly dividend
NT$0.32
Ex-dividend date
Jun 9, 2026
P/E ratio
16.17
52-wk high
NT$38.70
52-wk low
NT$27.00
EPS
NT$1.81
Shares outstanding
99.69M
No. of employees
641
News stories
From sources across the web
About Apex Biotechnology Corp
CEO-
Employees641
Founded1997
Headquarters-
SectorMedical device
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
509.95M
437.21M
438.99M
519.72M
Cost of goods sold
373.05M
330.39M
306.63M
344.06M
Cost of revenue
373.05M
330.39M
306.63M
344.06M
Research and development expenses
36.96M
35.94M
36.02M
37.23M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56.59M
57.27M
62.79M
60.29M
Operating expense
93.64M
98.80M
99.12M
88.45M
Total operating expenses
466.69M
429.19M
405.75M
432.51M
Operating income
43.26M
8.02M
33.24M
87.21M
Other non operating income
360.00K
775.00K
894.00K
313.00K
EBT including unusual items
22.16M
29.21M
58.17M
86.91M
EBT excluding unusual items
-938.00K
34.02M
57.52M
86.91M
Income tax expense
-6.60M
7.12M
7.97M
5.54M
Effective tax rate
-29.80%
24.37%
13.70%
6.38%
Other operating expenses
-
-
-
-
Net income
28.65M
22.14M
50.08M
81.28M
Net profit margin
5.62%
5.06%
11.41%
15.64%
Earnings per share
-
-
-
-
Interest and investment income
5.69M
139.00K
1.49M
219.00K
Interest expense
-851.00K
-835.00K
-822.00K
-829.00K
Net interest expenses
4.84M
-696.00K
665.00K
-610.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
55.93M
20.24M
45.47M
101.82M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more